Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis

CE Orhan, A Önal, Y Uyanıkgil, S Ülker - European journal of pharmacology, 2013 - Elsevier
Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …
被引用次数：9 相关文章

Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis.

CE Orhan, A Önal, Y Uyanıkgil… - European Journal of …, 2013 - europepmc.org
Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …

Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis

CE Orhan, A Önal, Y Uyanıkgil… - European journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …

Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis

CE Orhan, A Önal, Y Uyanıkgil, S Ülker - European Journal of …, 2013 - infona.pl
Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …
[PDF] academia.edu

[PDF][PDF] Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis

CE Orhan, A Onal, Y Uyanıkgil, S Ulker - 2013 - academia.edu
abstract Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …
[PDF] academia.edu

[PDF][PDF] Antihyperalgesic and antiallodynic effect of sirolimus in rat model of adjuvant arthritis

CE Orhan, A Onal, Y Uyanıkgil, S Ulker - European Journal of …, 2013 - academia.edu
abstract Sirolimus is an immunosupressive drug that specifically inhibit the activation of T-
lymphocytes. This study was undertaken to investigate whether treatment with sirolimus …